Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 18, Issue 1, 2004, Pages 176-178

  Li, Jin H ^a   Huang, Xiao R ^a   Zhu, Hong Jian ^a   Oldfield, Matthew ^a   Cooper, Mark ^a   Truong, Luan D ^a   Johnson, Richard J ^a   Lan, Hui Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; COLLAGEN; DNA BINDING PROTEIN; ENZYME INHIBITOR; IMMUNOGLOBULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; SMAD7 PROTEIN; SMAD7 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DRUG ANTAGONISM; HUMAN; KINETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELLS, CULTURED; COLLAGEN; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DNA-BINDING PROTEINS; ENZYME INHIBITORS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KINETICS; MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

MLCS; MLOWN;

EID: 1342268353     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.02-1117fje     Document Type: Article

References (0)